Gonadotropin-releasing hormone agonists

Higashijima T, Kataoka A, Nishida T, YakushijiM (1996) Gonadotropin-releasing hormone agonist therapy induces apoptosis in uterine leiomyoma. Eur J Obstet Gynecol Reprod Biol 68 169-173... [Pg.317]

Palomba S, Affinito P, Di Carlo C, Bifulco G, Nappi C (1999) Longterm administration of tibolone plus gonadotropin-releasing hormone agonist for treatment of uterine leiomyomas effectiveness and effects on vasomotor symptoms, bone mass, and lipid profile. Fertil Steril 72 889-895... [Pg.318]

Palomba S, Orio F Jr, Morelli M, Russo T, Pellicano M, Nappi C, Mastrantonio P, Lombardi G, Colao A, Zullo F (2002c) Raloxifene administration in women treated with gonadotropin releasing hormone agonist for uterine leiomyomas effects on bone metabolism. J Clin Endocrinol Metab 87 4476-4481... [Pg.318]

Palomba et al. (2004) have also studied the effects on cognigtion, mood, and QoL in 100 premenopausal women with symptomatic uterine leiomyomas treated with gonadotropin-releasing hormone agonist with or without raloxifene. The findings demonstrate that raloxifene is not able to prevent decreases in cognitive function and does not reduce the depresion and anxiety symptoms in women treated with GnRHa. [Pg.337]

Palomba S, Orio F Jr, Russo T, Falbo A, Amati A, Zullo F (2004) Gonadotropin-releasing hormone agonist with or without raloxifene effects on cognition, mood, and quality of life. Fertil Steril 82 480-482... [Pg.339]

Bayhan G, Bahceci M, Demirkol T, Ertem M, Yalinkaya A, Erden AC. A comparative study of a gonadotropin-releasing hormone agonist and finasteride on idiopathic hirsutism. Clin Exp Obstet Gynecol 2000 27 203-6. [Pg.158]

Yim SF, Lau TK, Sahota DS, Chung TK, Chang AM, Haines CJ. Prospective randomized study of the effect of add-back hormone replacement on vascular function during treatment with gonadotropin-releasing hormone agonists. Circulation 1998 98(16) 1631—5. [Pg.491]

Warnock JK, Bundren JC, Morris DW. Depressive symptoms associated with gonadotropin-releasing hormone agonists. Depress Anxiety 1998 7(4) 171-7. [Pg.492]

Fogelman I. Gonadotropin-releasing hormone agonists and the skeleton. Fertil Steril 1992 57(4) 715-24. [Pg.493]

Stoch SA, Parker RA, Chen L, Bubley G, Ko YJ, Vincelette A, Greenspan SL. Bone loss in men with prostate cancer treated with gonadotropin-releasing hormone agonists. J Clin Endocrinol Metab 2001 86(6) 2787-91. [Pg.493]

Pazos F, Escobar-Morreale HF, Balsa J, Sancho JM, Varela C. Prospective randomized study comparing the long-acting gonadotropin-releasing hormone agonist triptorelin, flutamide, and cyproterone acetate, used in combination with an oral contraceptive, in the treatment of hirsutism. Fertil Steril 1999 71(l) 122-8. [Pg.494]

Labrie F, Belanger A, Luu-The V, et al. Gonadotropin-releasing hormone agonists in the... [Pg.456]

A2. Antoniazzi, F., Bertoldo, F., Lauriola, S., Sirpresi, S., Gasperi, E., etal., Prevention of bone demineralization by calcium supplementation in precocious puberty during gonadotropin-releasing hormone agonist treatment. J. Clin. Endocrinol. Metab. 84, 1992-1996 (1999). [Pg.287]

B2. Balasch, J., Creus, M., Fabregues, F., Carmona, F., Casamitjana, R., et al., Inhibin, follicle-stimulating hormone, and age as predictors of ovarian response in in vitro fertilization cycles stimulated with gonadotropin-releasing hormone agonist-gonadotropin treatment. Am. J. Ob-stet. Gynecol. 175,1226-1230 (1996). [Pg.320]

E3. Edelstein, M. C., Seltman, H. J., Cox, B. J., Robinson, S. M., Shaw, R. A., and Muasher, S. J., Progesterone levels on the day of human chorionic gonadotropin administration in cycles with gonadotropin-releasing hormone agonist suppression are not predictive of pregnancy outcome. Fertil. Steril. 54, 853-857 (1990). [Pg.322]

F10. Forman, R. G., Robinson, J., Egan, D., Ross, C., Gosden, B., and Barlow, D. H., Follicular monitoring and outcome of in vitro fertilization in gonadotropin-releasing hormone-agonist-treated cycles. Fertil. Steril. 55, 567-573 (1991). [Pg.323]

W2. Winslow, K. L., Toner, J. P., Brzyski, R. G., Oehninger, S. C., Acosta, A. A., and Muasher, S. J., The gonadotropin-releasing hormone agonist stimulation test—A sensitive predictor of performance in the flare-up in vitro fertilization cycle. Fertil. Steril. 56, 711-717 (1991). [Pg.331]

Casadesus G, Garrett MR, Webber KM, Hartzler AW, Atwood CS, Perry G, Bowen RL, Smith MA (2006) The estrogen myth potential use of gonadotropin-releasing hormone agonists for the treatment of Alzheimer s disease. Drugs R D 7 187-193... [Pg.620]

Tahara M, Matsuoka T, Yokoi T, Tasaka K, Kurachi H, Murata Y. Treatment of endometriosis with a decreasing dosage of a gonadotropin-releasing hormone agonist (nafarelin) a pilot study with low-dose agonist therapy ( draw-back therapy). Fertil SterU 2000 73(4) 799-804. [Pg.1534]

Trade names Profact Receptal Suprecor Suprecur (Sanofi-Aventis) Suprefact (Sanofi-Aventis) Suprefact Pro Suprefakt Indications Prostate cancer, endometriosis, uterine fibrosis. Category Gonadotropin-releasing hormone agonist Half-life 80 minutes... [Pg.83]

Trade names Prozoladex Zoladex (AstraZeneca) Indications Breast and prostate carcinoma, endometriosis Category Gonadotropin-releasing hormone agonist Half-life 5 hours... [Pg.269]

Category Gonadotropin-releasing hormone agonist Half-life 3 hours... [Pg.398]

Leuprolide, a gonadotropin-releasing hormone agonist, reestablishes spermatogenesis after 2,5-hexanedione-indu-ced irreversible testicular injury in the rat, resulting in normalized stem cell factor expression. Endocrinology 139 236 44... [Pg.146]

Salerno M, Di Maio S, Gasparini N, Mariano A, Macchia V, Tenore A. Central precocious puberty A single blood sample after gonadotropin-releasing hormone agonist administration in monitoring treatment. Horm Res 1998 50 205-11. [Pg.2148]

Ovulation suppression (e.g., oral contraceptives, danazol, gonadotropin-releasing hormone agonists) should be used before resorting to surgical therapy in women with severe PMDD. [Pg.1465]

Nonsteroidal anti-inflammatory drugs ibuprofen, ketoprofen, naproxen sodium Alternative bromocriptine, danazol, oral contraceptives, gonadotropin releasing hormone agonist estrad iol/progesterone add-back therapy Migraines Caffeine restriction... [Pg.1473]

Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...